Key Details
Price
$19.29Last Dividend
$0.42Annual Revenue
$92.46 MAnnual EPS
$2.33Annual ROE
12.37%Beta
0.51Events Calendar
Next earnings date:
Feb 21, 2025Recent quarterly earnings:
Nov 11, 2024Recent annual earnings:
Feb 21, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
Dec 31, 2024Next split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
Market Data
Dividend
Profitability
Efficiency
Valuation
Liquidity
Cash Flow
Institutional Ownership
CCAP is a defensive BDC with a 90% concentration on first-lien debt, ensuring high repayment priority during potential litigation processes. The portfolio focuses on non-cyclical businesses (85%), providing safety and predictability of cash flows, and the median EBITDA of its portfolio companies amounts to $27m. CCAP offers substantial distributions, including a $0.42 quarterly dividend per share and additional supplemental distributions, making it an attractive income holding.
Item 1.01. Entry into a Material Definitive Agreement On December 3, 2024, Crescent Capital BDC, Inc. (the "Company") and certain subsidiaries of the Company entered into an Amended and Restated Senior Secured Revolving Credit Agreement (the "Revolving Credit Agreement") with Sumitomo Mitsui Banking Corporation as Administrative Agent ("Agent"), Collateral Agent, Lead Arranger, Sole Bookrunner and a lender, and certain other lenders named therein. aAdsList.push('Article'); aAdsListSize.push([300, 250]); aAdsListCA.push(null); The Revolving Credit Agreement amended and restated an existing Senior Secured Revolving Credit Agreement with Agent and, among other things, (i) decreased the size of the aggregate revolving commitment from up to $350,000,000.00 to up to $285,000,000.00, (ii) added an initial term commitment in an amount not to exceed $25,000,000.00 for an aggregate facility size of $310,000,000.00, (iii) increased the interest rate by 0.125% so that borrowings under the revolving commitment will bear interest at the applicable benchmark rate plus (A) 1.125% per annum for ABR Loans and 2.125% per annum for Term Benchmark Loans and RFR Loans if the Borrowing Base is less than 1.60 times the Combined Debt Amount and (B) 1.000% per annum for ABR Loans and 2.000% for Term Benchmark Loans and RFR Loans if the Borrowing Base is equal to or greater than 1.60 times the Combined Debt Amount, in each case, on outstanding amounts, or as otherwise determined by the Revolving Credit Agreement, (iii) extended the facility termination date from October 27, 2026 to December 3, 2029, unless otherwise terminated earlier under the Revolving Credit Agreement, and (iv) extended the facility revolving commitment period termination date from October 27, 2025, to December 1, 2028, unless otherwise terminated earlier under the Revolving Credit Agreement. Borrowings under the Revolving Credit Agreement remain subject to leverage restrictions contained in the Investment Company Act of 1940, as amended. The description above is only a summary of the material, amended provisions of the Revolving Credit Agreement and is qualified in its entirety by reference to a copy of the Revolving Credit Agreement, which is filed as Exhibit 10.1 to this current report on Form 8-K.Attachments Original document Permalink DisclaimerCrescent Capital BDC Inc. published this content on December 06, 2024, and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on December 06, 2024 at 11:02:02.990.
Inflation makes Crescent Capital and Crown Castle compelling income-generating investments with yields of 9% and 6%, respectively. Crescent Capital offers a diversified portfolio with a strong 1st lien loan focus, high dividend coverage, and potential for capital appreciation. Crown Castle benefits from growing data demand and AI trends, providing essential infrastructure with a solid balance sheet and attractive valuation.
Crescent Capital's strong dividend coverage and NAV growth indicate a resilient portfolio. The current dividend yield is 9.7% and is well supported by earnings. The portfolio, valued at $1.6B, is concentrated in health care and software, with 97% of debt investments on a floating rate basis. The rate of non-accruals still remains low, showing portfolio company resilience. This highlights CCAP's high-quality underwriting and financial health.
Crescent Capital BDC (CCAP) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Income investors should consider Crescent Capital BDC and Fidus Investment for their portfolios, as both trade below Net Asset Values and offer growth potential. CCAP, despite a short track record, shows strong investment activity, solid balance sheet, and consistent dividend payouts, making it a defensively positioned growth opportunity. FDUS has a longer track record, impressive dividend growth, and a solid balance sheet with a lower leverage ratio, offering stability and income reliability.
An investor's cash flow should be measured alongside net worth as a measure of financial resiliency. Crescent Capital offers an 8.9% yield, focusing on first-lien loans in cash flow-generating, private equity-backed middle-market businesses, with a robust portfolio and strong financials. Federal Realty, a top-tier REIT, provides a 3.9% yield, high-quality mixed-use properties in affluent areas, and a 57-year streak of dividend increases.
Crescent Capital BDC has a well-diversified, defensive portfolio with 89.2% first-lien debt and decreasing non-accruals, indicating high portfolio quality. CCAP is sensitive to interest rate cuts due to its floating-rate debt investments, but lower interest expenses and increased market activity could somewhat offset this. Despite potential interest rate cuts, CCAP's dividends remain well-covered, with a strong net investment income per share providing robust dividend coverage.
Let's talk about a “rich guy loophole” that you and I can take advantage of—and bank dividends up to 12.5%.
Recently, Crescent Capital has outperformed the BDC market delivering positive returns, while the index has dropped in the negative return territory. Q2, 2024 earnings deck helps explain this, where we can see a continued generation of robust cash flows, solid portfolio quality and improved transaction outlook. In this article, I dissect the Q2 earnings and explain in detail why I have remained bullish.
FAQ
- What is the primary business of Crescent Capital BDC?
- What is the ticker symbol for Crescent Capital BDC?
- Does Crescent Capital BDC pay dividends?
- What sector is Crescent Capital BDC in?
- What industry is Crescent Capital BDC in?
- What country is Crescent Capital BDC based in?
- When did Crescent Capital BDC go public?
- Is Crescent Capital BDC in the S&P 500?
- Is Crescent Capital BDC in the NASDAQ 100?
- Is Crescent Capital BDC in the Dow Jones?
- When was Crescent Capital BDC's last earnings report?
- When does Crescent Capital BDC report earnings?
- Should I buy Crescent Capital BDC stock now?